TRxADE HEALTH, Inc. (MEDS)

TRxADE HEALTH Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	6.66	8.27	10.25	9.89	17.12	7.44
Revenue Growth (YoY)	-17.60%	-19.30%	3.65%	-42.24%	130.26%	94.07%
Cost of Revenue	5.56	5.67	4.73	5.14	11.42	2.57
Gross Profit	1.1	2.6	5.52	4.75	5.71	4.87
Selling, General & Admin	11.2	7.02	6.1	6.44	7.49	4.38
Research & Development	1.27	1.38	0.99	0.9	0	0
Other Operating Expenses	1.51	1.47	1.34	2.7	0.73	0.37
Operating Expenses	13.98	9.86	8.44	10.04	8.21	4.75
Operating Income	-12.88	-7.26	-2.92	-5.29	-2.51	0.13
Interest Expense / Income	1.23	1.2	0.34	0.02	0.03	0.05
Other Expense / Income	-18.14	9.38	0.22	-	-	0.36
Pretax Income	4.03	-17.84	-3.47	-5.32	-2.54	-0.28
Net Income	4.03	-17.84	-3.47	-5.32	-2.54	-0.28
Shares Outstanding (Basic)	1	1	1	1	1	0
Shares Outstanding (Diluted)	1	2	1	1	1	0
Shares Change	88.90%	320.30%	4.45%	5.60%	29.96%	1.76%
EPS (Basic)	-1.69	-23.36	-6.15	-9.75	-4.95	-0.75
EPS (Diluted)	11.27	-7.49	-6.13	-9.75	-4.95	-0.75
Free Cash Flow	-11.24	-2.07	-1.56	-2.59	-2.25	0.06
Free Cash Flow Per Share	-10.85	-2.71	-2.77	-4.77	-4.38	0.15
Dividend Per Share	8.000	-	-	-	-	-
Gross Margin	16.52%	31.41%	53.85%	47.99%	33.33%	65.50%
Operating Margin	-193.35%	-87.80%	-28.45%	-53.51%	-14.64%	1.68%
Profit Margin	60.50%	-215.70%	-33.87%	-53.75%	-14.81%	-3.82%
Free Cash Flow Margin	-168.80%	-25.07%	-15.26%	-26.18%	-13.15%	0.80%
EBITDA	6.27	-15.6	-2.94	-5.15	-2.4	-0.14
EBITDA Margin	94.13%	-188.53%	-28.69%	-52.11%	-14.04%	-1.84%
Depreciation & Amortization	1.01	1.05	0.19	0.14	0.1	0.09
EBIT	5.26	-16.65	-3.14	-5.29	-2.51	-0.23
EBIT Margin	79.03%	-201.22%	-30.59%	-53.51%	-14.64%	-3.11%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).